We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Transgenomic, Inc. To Purchase Clinical Data, Inc.'s Diagnostic Business

News   Nov 30, 2010

 
Transgenomic, Inc. To Purchase Clinical Data, Inc.'s Diagnostic Business
 
 
Advertisement
 

RELATED ARTICLES

Rapid Genome Sequencing of SARS-CoV-2 Identifies Connected Cases in Hospital

News

Cambridge researchers have shown how rapid genome sequencing of virus samples and enhanced testing of hospital staff can help to identify clusters of healthcare-associated COVID-19 infections.

READ MORE

Team Designs New Cancer Drug Called Fadraciclib

News

Scientists have revealed details of the discovery of a new cancer drug called fadraciclib, that could be used to treat a range of cancer types, including blood cancers and solid tumors.

READ MORE

SARS-CoV-2 Immunity Rapidly Declines Within Months of Infection

News

A recent preprint study indicates that there is a rapid decline in the levels of SARS-CoV-2 neutralizing antibodies during the weeks following initial infection. This raises questions over the potential for re-infection, the effectiveness that may be expected from vaccination and the viable window for antibody testing in disease surveillance.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE